Medulloblastoma - 50 Studies Found
Recruiting |
: Study of Nifurtimox to Treat Refractory or Relapsed Neuroblastoma or Medulloblastoma :
: 2008-01-14 :
|
Recruiting |
: HeadStart4: Newly Diagnosed Children (<10 y/o) With Medulloblastoma and Other CNS Embryonal Tumors :
: |
Recruiting |
: Modified Measles Virus (MV-NIS) for Children and Young Adults With Recurrent Medulloblastoma or Recurrent ATRT :
|
Completed |
: TPI 287 in Patients With Refractory or Recurrent Neuroblastoma or Medulloblastoma :
: Drug: TPI 287 Three patients will be enrolled to receive single agent TPI 287 IV administered on Days 1, |
Recruiting |
: A Two-Part Study of TB-403 in Pediatric Subjects With Relapsed or Refractory Medulloblastoma : Relapsed or Refractory Medulloblastoma (MB) (Part A: Also Include Neuroblastoma (NB), Ewing Sarcoma (ES) and Alveolar Rhabdomyosarcoma (ARMS)) : 2016-04-08 :
|
Withdrawn |
: A Study of LY2940680 in Pediatric Medulloblastoma or Rhabdomyosarcoma :
: 2012-09-28 :
|
Not yet recruiting |
: Reduced Craniospinal Radiation Therapy and Chemotherapy in Treating Younger Patients With Newly Diagnosed WNT-Driven Medulloblastoma : Untreated Childhood Medulloblastoma : 2016-03-25 :
|
Completed |
: Combination Chemotherapy in Treating Younger Patients With Newly Diagnosed, Non-Metastatic Desmoplastic Medulloblastoma : Untreated Childhood Medulloblastoma : 2013-12-13 :
|
Completed |
: Vismodegib in Treating Younger Patients With Recurrent or Refractory Medulloblastoma : Recurrent Childhood Medulloblastoma : 2010-11-10 :
|
Completed |
: GDC-0449 in Treating Young Patients With Medulloblastoma That is Recurrent or Did Not Respond to Previous Treatment : Recurrent Childhood Medulloblastoma : 2009-01-13 :
|